Diabetes in Primary Care course MCQ Answers 2016

Similar documents
SHORT CLINICAL GUIDELINE SCOPE

Diabetes Mellitus 1. Chapter 43. Diabetes Mellitus, Self-Assessment Questions

Type 2 Diabetes workshop notes

Workshop A Tara Kadis

TYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS

Therapy Insulin Practical guide to Health Care Providers Quick Reference F Diabetes Mellitus in Type 2

Insulin or GLP1 How to make this choice in Practice. Tara Kadis Lead Nurse - Diabetes & Endocrinology Mid Yorkshire Hospitals NHS Trust

Insulin use in Type 2 Diabetes. Dr Rick Cutfield. Why? When? How?

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Trends in Prescribing of Drugs for Type 2 Diabetes in General Practice in England (Chart 1) Other intermediate and long-acting insulins

User guide Basal-bolus Insulin Dosing Chart: Adult

Initiate Atorvastatin 20mg daily

Understanding Your Diabetes HELPLINE:

Pharmacological Glycaemic Control in Type 2 Diabetes

Newcastle Mitochondrial Disease Guidelines

Initiating & titrating insulin & switching in General Practice Workshop 1

Guideline for Insulin Therapeutic Review in patients with Type 2 Diabetes

Glycaemic Control in Adults with Type 1 Diabetes

Leicestershire Diabetes Guidelines: Insulin Therapy

Information for Patients

INSULIN INITIATION IN TYPE 2 DIABETES IN PRIMARY CARE

The GP Update Handbook Spring 2013

Renal Disease in Type 2 Diabetes Mellitus

Type 2 Diabetes. Aims and Objectives. What did you consider? Case Study One: Miss S. Which to choose?!?! Modes of Action

Lead Clinician(S) (DATE) Approved by Diabetes Directorate on: Approved by Medicines Safety Group on: This guideline should not be used after end of:

Type 2 Diabetes and Prediabetes: A New Understanding of Cause and Treatment. Bruce Latham, M.D. Endocrine Specialists Greenville Health System

Managing diabetes in the post-guideline world. Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ)

Mary Bruskewitz APN, MS, RN, BC-ADM Clinical Nurse Specialist Diabetes

End of Life Diabetes Care

Type 2 Diabetes: When to Initiate And Intensify Insulin Therapy. Julie Bate on behalf of: Dr John Wilson Endocrinologist Capital and Coast DHB

Type 2 Diabetes. Tabinda Dugal GP Day 4/05/16


Prescribing for Diabetes. England to

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU

The Early Use of Insulin and Oral Anti diabetic Drugs

Managing the risks of commencing insulin therapy for patients with type 2 diabetes

Diabetes Fundamentals

INSULIN INTENSIFICATION: Taking Care to the Next Level

INSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT?

Understanding diabetes Do the recent trials help?

When and how to start insulin: strategies for success in type 2 diabetes

Insulin myths and facts

Insulin switch & Algorithms Rotorua GP CME June Kingsley Nirmalaraj FRACP Endocrinologist BOPDHB

Overview and update of modern type 2 Diabetes philosophy and management. Dr Steve Stanaway Consultant Endocrinologist BCU

Harmony Clinical Trial Medical Media Factsheet

Double Diabetes: Definition, Diagnosis, Treatment, Prediction and Prevention.

Prescribing for Diabetes, England to

Nutrition Therapy in Diabetes Mellitus. Dorothy Debrah Diabetes Specialist Dietitian University Hospital, Llandough. Wales, UK February 2012

A Guide to Monitoring Blood Glucose for Patients with diabetes in Care Homes

Comparing Medications for Adults With Type 2 Diabetes Focus of Research for Clinicians

Type 2 Diabetes - Referral Criteria to Specialist Services

Add: 2 nd generation sulfonylurea or glinide or Add DPP-4 inhibitor Start or intensify insulin therapy if HbA1c goals not achieved with the above

Cancer treatment and diabetes

DR. Trinh Thi Kim Hue

INSULIN TREATMENT FOR TYPE 2 DIABETES MANAGEMENT

Management of diabetes

Clinical Assistant Professor. Clinical Pharmacy Specialist Wesley Family Medicine Residency Program. Objectives

Insulin onset, peak and duration of action

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

DRUGS FOR GLUCOSE MANAGEMENT AND DIABETES

Summary of the risk management plan (RMP) for Xultophy (insulin degludec / liraglutide)

Update on the management of Type 2 Diabetes

Treatment of patients with type 2 diabetes: from text book therapy to personalized medicine

A patient s guide to the. management of diabetes at the time of surgery

Type 2 Diabetes. Management and Medication. HELPLINE:

CASE B1. Newly Diagnosed T2DM in Patient with Prior MI

This guideline is the NICE Diabetes in Pregnancy guideline with additions where appropriate to explain implementation within UHL.

Dudley Diabetes Management Guidelines for Adults with Type 2 Diabetes

Specialist Clinics Day Regularity Site Contact

Peri-Operative Guidelines for Management of Diabetes Patients

Insulin Pump Therapy

Cochrane Quality and Productivity topics

of Treatment Options for Type 2 Diabetes Patients

DOCUMENT CONTROL PAGE

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

4. Does your PCT provide structured education programmes for people with type 2 diabetes?

Approximate Cost Reference List i for Antihyperglycemic Agents

DIABETES MELLITUS. By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria

Chapter 4 Type 2 Diabetes

Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference

NICE guideline Published: 26 August 2015 nice.org.uk/guidance/ng17

Abdulaziz Al-Subaie. Anfal Al-Shalwi

Management of Children with newly diagnosed type 1 diabetes (up until their 18th Birthday)

This information explains the advice about type 2 diabetes in adults that is set out in NICE guideline NG28.

Treatment of Type 2 Diabetes

trends in the treatment of Diabetes type 2 - New classes of antidiabetic drugs. IAIM, 2015; 2(4): 223-

Management of Diabetes: A Primary Care Perspective. Presentation Outline

G:\ CDM\BHCIG Diabetes Pathway FINAL September 05.doc 1

Jill Malcolm, Karen Moir

Insulin therapy in type 2 diabetes When and how? Disclosures. Learning Objectives. None relevant to today s talk

Diabetes: When To Treat With Insulin and Treatment Goals

Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT

Institute of Applied Health Sciences. University of Aberdeen DATABASE REVIEW. Grampian University. Hospitals NHS Trust GRAMPIAN DIABETES

NICE guideline Published: 26 August 2015 nice.org.uk/guidance/ng18

Diabetes mellitus. Lecture Outline

Hyperosmolar Non-Ketotic Diabetic State (HONK)

Updates for your practice March, Vol 2, Issue 14 TLALELETSO. Managing Complicated Diabetes

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Treating Type 2 Diabetes Mellitus: a New York State Medicaid Clinical Guidance Document

Type 2 Diabetes in Children

Transcription:

Diabetes in Primary Care course MCQ Answers 2016 Diagnosis of Diabetes HbA1C should not be used as a diagnostic tool in the following situations: (answer each TRUE or FALSE) 1. Gestational Diabetes TRUE 2. Chronic iron deficiency anaemia TRUE 3. Steroid-induced diabetes FALSE 4. Pancreatic diabetes TRUE 5. Recent blood transfusion TRUE Classification of Diabetes The following are typical features of Maturity Onset Diabetes of the Young (MODY): (answer each TRUE or FALSE) 1. Low or absent C-peptide levels FALSE 2. Overweight or obese BMI FALSE 3. Presence of pancreatic autoantibodies FALSE 4. Insulin dependence FALSE 5. Marked features of insulin resistance FALSE Pre-diabetes & the prevention of T2D The Finnish Diabetes Prevention Study demonstrated that early intensive lifestyle intervention can prevent the progression to T2DM. The NNT to prevent 1 case of T2DM over 13 years of follow-up was: (choose one) 1. 5 * 2. 25 3. 50 4. 75 5. 100 HbA1C Targets in Diabetes The recently published NICE guidance on the management of T1DM encourage us to support all adults with T1DM to aim for a target HbA1C of: (choose one) 1. 42mmol/mol (6%) 2. 48mmol/mol (6.5%)* 3. 53mmol/mol (7%) 4. 58mmol/mol (7.5%) 5. 64mmol/mol (8%)

Tight glycaemic control ideally striving for an HbA1C 48mmol/mol (6.5%) is appropriate for the following patients: (answer each TRUE or FALSE) 1. A 70-year-old man with >10 years duration T2DM FALSE 2. A 40-year-old lady newly diagnosed with T2DM TRUE 3. A 65-year-old man with a background of IHD and stenting and T2DM for 7 years FALSE 4. A 55-year-old man with inoperable pancreatic cancer and pancreatic diabetes FALSE 5. A 70-year-old man with dementia and newly diagnosed T2DM FALSE Dietary management and behaviour change in diabetes The following are structured education programmes for T2DM: (answer each TRUE or FALSE) 1. DESMOND TRUE 2. X-PERT TRUE 3. BERTIE FALSE 4. DAFNE FALSE 5. RECLAIM FALSE Examples of low glycaemic index (GI) foods include: (answer each TRUE or FALSE) 1. Cornflakes FALSE 2. Baked potatoes FALSE 3. Muesli TRUE 4. Cow s milk TRUE 5. Cous cous FALSE When counting carbohydrates, 1 carbohydrate serving equals how many grams of carbohydrate: (choose one) 1. 5g 2. 10g 3. 15g* 4. 20g 5. 25g 1 pint of draught Guinness contains how many calories: (choose one) 1. 150kcal 2. 200kcal* 3. 250kcal 4. 300kcal 5. 350kcal

The Pharmacological Management of Hyperglycaemia At what egfr should metformin therapy be stopped due to concerns regarding lactic acidosis: 1. 15 2. 30* 3. 45 4. 60 5. No need to stop The following drugs do not cause hypoglycaemia (answer each TRUE or FALSE) 1. Metformin TRUE 2. Sulphonylureas FALSE 3. Pioglitazone TRUE 4. Gliptins TRUE 5. GLP1 analogues TRUE The following drugs do not cause weight gain (answer each TRUE or FALSE) 1. Metformin TRUE 2. Sulphonylureas FALSE 3. Pioglitazone FALSE 4. Gliptins TRUE 5. GLP1 analogues TRUE The following classes of drugs have established cardiovascular safety data (answer each TRUE or FALSE) 1. Metformin TRUE 2. Sulphonylureas FALSE 3. SGLT2 inhibitors TRUE 4. Gliptins TRUE 5. GLP1 analogues TRUE NICE recommends the following as first line treatment when starting insulin therapy in T2DM (answer each TRUE or FALSE) 1. Biphasic (pre-mixed) insulin e.g. Humulin M3 FALSE 2. Long-acting insulin analogue e.g. insulin glargine (Lantus) FALSE 3. Rapid-acting insulin e.g. Novorapid FALSE 4. Ultra-lomg acting insulin e.g. insulin degludec (Tresiba) FALSE 5. Human isophane insulin e.g. Insulatard TRUE

The following insulin types need to be resuspended prior to injection: (answer each TRUE or FALSE) 1. Biphasic (pre-mixed) insulin e.g. Humulin M3 TRUE 2. Long-acting insulin analogue e.g. insulin glargine (Lantus) FALSE 3. Rapid-acting insulin e.g. Novorapid FALSE 4. Ultra-lomg acting insulin e.g. insulin degludec (Tresiba) FALSE 5. Human isophane insulin e.g. Insulatard TRUE The following GLP1 drugs are administered weekly: (answer each TRUE or FALSE) 1. Exenatide (Bydureon) TRUE 2. Exenatide (Byetta) FALSE 3. Lixisenatide (Lyxumia) FALSE 4. Liraglutide (Victoza) FALSE 5. Dulaglutide (Trulicity) TRUE The following GLP1 drugs should be administered up to 1 hour before food: (answer each TRUE or FALSE) 1. Exenatide (Bydureon) FALSE 2. Exenatide (Byetta) TRUE 3. Lixisenatide (Lyxumia) TRUE 4. Liraglutide (Victoza) FALSE 5. Dulaglutide (Trulicity) FALSE Diabetes in Pregnancy Which of the following are the NICE 2015 criteria for diagnosing gestational diabetes: (choose one)? 1. FBG 5.1mmol/l or 2hr BG post 75g OGTT 8.5mmol/l 2. FBG 5.6mmol/l or 2hr BG post 75g OGTT 7.8mmol/l * 3. FBG 5.6mmol/l or 2hr BG post 75g OGTT 11.1mmol/l 4. FBG 7.0mmol/l or 2hr BG post 75g OGTT 7.8mmol/l 5. FBG 7.0mmol/l or 2hr BG post 75g OGTT 11.1mmol/l The management of cardiovascular risk factors in diabetes According to NICE CG181 July 2014: CV risk assessment and reduction, the following people should be offered atorvastatin 20mg: (answer each TRUE or FALSE) 1. A 34-year-old female who developed T1DM aged 21 years TRUE 2. All those aged over 40 years with T2DM FALSE 3. A 44-year-old man with T2DM and CKD3 TRUE 4. A 42-year-old female with T2DM and a 10-year CV risk score of 12% TRUE 5. An 18-year-old man newly diagnosed with T1DM FALSE

Diabetic nephropathy 1. A person with egfr 25 and ACR 15 is classified as having CKD G4A3 FALSE 2. Increased ACR and decreased GFR in combination multiple the risk of adverse outcomes TRUE 3. CKD is an independent risk factor for developing CVD TRUE 4. CKD does not directly cause hypoglycaemia FALSE 5. Lowering HbA1C to 53mmol/mol (7%) improves renal outcomes in CKD FALSE Diabetic foot disease The foot assessment of the following people with T2DM would be classified as moderate risk: (answer each TRUE or FALSE) 1. Peripheral pulses present and sensation intact but evidence of callus formation TRUE 2. Peripheral pulses present, sensation and skin intact but inappropriate footwear FALSE 3. History of previous foot ulceration since successfully treated FALSE 4. Peripheral pulses present but loss of monofilament sensation and skin intact TRUE 5. Unexplained hot, red, swollen foot FALSE Depression and distress in diabetes 1. Depression and anxiety is 5 times as common in those with T1DM and T2DM compared to the general population FALSE 2. Depression in diabetes is associated with an increased risk of mortality TRUE 3. Major depression in T2DM is associated with an increased risk of macrovascular and macrovascular complications TRUE 4. Paroxetine is the best option for treating depression in diabetes FALSE 5. Diabetes distress is a DSM-V defined disorder FALSE Diabetic neuropathy The following conditions can mimic painful diabetic neuropathy (answer each TRUE or FALSE) 1. Osteoarthritis TRUE 2. Intermittent claudication TRUE 3. Plantar fasciitis TRUE 4. Tarsal tunnel syndrome TRUE 5. Radiculopathy TRUE

Abnormal blood tests in diabetes 1. Around 50% of men with T2Dm have evidence of hypogonadotrophic hypogonadism FALSE 2. Testosterone levels of 8nmol/L are suggestive of a true androgen deficiency in an overweight person with T2DM FALSE 3. In those with established hypothyroidism levothyroxine dose should be increased by 25mcg as soon as pregnancy is confirmed TRUE 4. All those with T2DM need an annual check of TFTs FALSE 5. An AST:ALT ratio of 1.1 suggests NAFLD with a low risk of progression to NASH FALSE Diabetic emergencies 1. DKA is always associated with hyperglycaemia FALSE 2. The mortality rate associated with hyperosmolar hyperglycaemic state is around 1-2% FALSE 3. The rate of hypoglycaemia in those with T2DM managed with sulphonylureas is similar to those with T2DM on insulin TRUE 4. Renal impairment doubles the risk of hypoglycaemia in T2DM TRUE 5. A blood ketone level of 3mmol/l can be safely managed at home FALSE